Pierzchalski Arkadiusz, Robitzki Andrea, Mittag Anja, Emmrich Frank, Sack Ulrich, O'Connor José-Enrique, Bocsi József, Tárnok Attila
Department of Pediatric Cardiology, Heart Center Leipzig, University of Leipzig, Leipzig, Germany.
Cytometry B Clin Cytom. 2008 Nov;74(6):416-26. doi: 10.1002/cyto.b.20453.
The finding that an individual's genome differs as much as by many million variants from that of the human reference assembly diminished the great enthusiasm that every disease could be predicted based on nucleotide polymorphisms. Even individual cells of an organ may be specifically equipped to perform specific tasks and that the information of individual cells in a cell system is key information to understand function or dysfunction. Therefore, cytomics received great attention during the last years as it allows to quantitatively and qualitatively analyzing great number of individual cells, cell constituents, and of their intracellular and functional interactions in a cellular system and also giving the concept of analysis of these data.Exhaustive data extraction from multiparametric assays and multiple tests are the prerequisite for prediction of drug toxicity. Cytomics, as novel approach for unsupervised data analysis give a chance to find the most predictive parameters, which describe best the toxicity of a chemical. Cytomics is intrinsically connected to drug development and drug discovery.Focused on small structures, nanobioengineering is the ideal partner of cytomics, the systems biological discipline for cell population analysis. Realizing the idea "from the molecule to the patient" develops and offers chemical compounds, proteins, and other biomolecules, cells as well as tissues as instruments and products for a wide variety of biotechnological and biomedical applications.The integrative nanobioengineering combining different disciplines of nanotechnology will promote the development of innovative therapies and diagnostic methods. It can improve the precision of the measurements with focus on single cell analysis. By nanobioengineering and whole body imaging techniques, cytomics covers the field from molecules through bacterial cells, eukaryotic tissues, and organs to small animal live analysis. Toxicological testing and medical drug development are currently strongly broadening. It harbors the promise to substantially impact on various fields of biomedicine, drug discovery, and predictive medicine.As the number of scientific data is rising exponentially, new data analysis tools and strategies like cytomics and nanobioengineering take a lead and get closer to application. Bionanoengineering may strongly support the quantitative data supply, thus strengthening the rational for cytomics approach.
个体基因组与人类参考基因组相比,存在多达数百万个变异,这一发现削弱了人们基于核苷酸多态性预测所有疾病的巨大热情。甚至一个器官中的单个细胞可能也具有执行特定任务的特殊装备,并且细胞系统中单个细胞的信息是理解功能或功能障碍的关键信息。因此,细胞组学在过去几年中受到了极大关注,因为它能够对细胞系统中大量的单个细胞、细胞成分及其细胞内和功能相互作用进行定量和定性分析,并给出这些数据分析的概念。从多参数检测和多项测试中进行详尽的数据提取是预测药物毒性的前提。细胞组学作为一种无监督数据分析的新方法,有机会找到最具预测性的参数,这些参数能最好地描述一种化学物质的毒性。细胞组学与药物开发和药物发现有着内在联系。纳米生物工程专注于微小结构,是细胞组学(细胞群体分析的系统生物学学科)的理想伙伴。实现“从分子到患者”的理念,开发并提供化合物、蛋白质和其他生物分子、细胞以及组织,作为用于各种生物技术和生物医学应用的工具和产品。整合不同纳米技术学科的综合纳米生物工程将促进创新疗法和诊断方法的发展。它可以提高以单细胞分析为重点的测量精度。通过纳米生物工程和全身成像技术,细胞组学涵盖了从分子到细菌细胞、真核组织、器官再到小动物活体分析的领域。毒理学检测和医学药物开发目前正在大幅拓展。它有望对生物医学、药物发现和预测医学的各个领域产生重大影响。随着科学数据数量呈指数级增长,像细胞组学和纳米生物工程这样的新数据分析工具和策略占据主导地位并更接近应用。生物纳米工程可能会大力支持定量数据供应,从而加强细胞组学方法的合理性。